BETR BetterLife Pharma Inc.

0.1328USD0.1900 CAD · CNQ-7.32%Mkt Cap: 86.51M USDP/E: —

BetterLife Pharma Inc., a biotechnology company, engages in the development of psychedelic-derived compounds. It focuses on developing and commercializing BETR-001, a non-hallucinogenic and non-controlled LSD derivative …

Institutional holders1 on file

Key Statistics

Company
Market Cap86.51M USD
Enterprise Value85.72M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.05M USD
Revenue/Share—
Last Price0.1328 USD
Fiscal Year EndJan 2026
MR QuarterJul 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA08772P2026
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-2.88
EPS (TTM)-0.02 USD
EPS (Forward)—
52W Range
0.028048% of range0.2482
52W High0.2482 USD
52W Low0.0280 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE15.28%
ROA-680.07%
ROIC—
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-437.22K USD
CapEx (TTM)—
FCF Margin—
FCF Yield-0.38%
Net Debt1.34M USD
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.13
Current Ratio0.21
Quick Ratio0.11
Book Value/Sh-0.05 USD
Cash/Share0.0014 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJun 26, 2020
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.651.34M
Float473.98M
Insiders14.33%
Institutions13.45%
Short Interest
Short Ratio0.5d
Short % Float0.03%
Short % Out.0.03%
Shares Short176.86K
Short (prev mo.)277.51K
Technical
SMA 500.1849 (-28.2%)
SMA 2000.1154 (+15.0%)
Beta0.25
S&P 52W Chg12.00%
Avg Vol (30d)376.69K
Avg Vol (10d)395.58K
Technical Indicators
RSI (14)40.3
MACD-0.0111
MACD Signal-0.0092
MACD Hist.-0.0019
BB Upper0.1782 USD
BB Middle0.1529 USD
BB Lower0.1277 USD
BB Width33.02%
ATR (14)0.0160 USD
Vol Ratio (20d)0.15x

About BetterLife Pharma (CNSX: BETR)

›

BetterLife Pharma (CNSX: BETR) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 0.1900 CAD on 19 November 2026, up 171.4% over 52 weeks. Its 52-week range is 0.0400 CAD to 0.3550 CAD: the price is 46.5% below the high and 375.0% above the low.

Its market capitalisation is 123.75M CAD.

BetterLife Pharma reports return on equity of 15.3% and an operating margin of 0.0%.

Its debt exceeds its cash by 1.92M CAD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.